Skip to main content

Discussion around the effects of cannabinol administration on oxytososis/ferroptosis via regulation of mitochondrial function

Please join us for a conversation about a study published in 2022 in the journal Free Radical Biology and Medicine entitled: “Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors”, in which Dr. Liang, Dr. Maher and Dr. Sitbon discuss the potential use of a lesser known cannabinoid called cannabinol (CBN) in inhibiting oxytosis/ferroptosis via regulation of mitochondrial function and the potential implications on their findings.

mm

Author Yoel H. Sitbon

Yoel is a Medical Writer in the Medical Content division at Csequence. His scientific expertise is in Neuroscience (neural mechanisms behind drug addiction) and Molecular & Cellular Pharmacology (molecular mechanisms behind mutations induced cardiovascular diseases). Yoel has over five years of scientific writing experience as evidenced by 8 peer-reviewed publications in scientific journals. He is an effective oral communicator having presented his PhD thesis work at many biomedical conferences nationally. He also has strong mentorship and leadership experience. Yoel has a B.S in Neuroscience at the University of California, Los Angeles and a Ph.D. in Molecular & Cellular Pharmacology at the University of Miami, Miller School of Medicine.

More posts by Yoel H. Sitbon